CPT code 82013 represents a quantitative laboratory assay for acetylcholinesterase (acetylhydrolase), an enzyme that hydrolyzes the neurotransmitter acetylcholine. This test is used in clinical and toxicology contexts to evaluate enzyme activity relevant to neuromuscular function and exposure to certain toxins or drugs. Nationally, accurate coding for specialized enzymatic assays affects laboratory reimbursement, utilization tracking, and clinical decision support.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides an overview of payer coverage patterns, reimbursement benchmarks, and billing considerations for laboratories and clinicians billing for 82013.

Readers will find: a concise clinical context for the assay, typical sites of service where the test is performed, commonly reported modifiers (listed separately), and guidance on where to look for related procedural and billing information. Data not available in the input is noted where applicable. The content is intended for a national audience of laboratory directors, billing professionals, and clinical stakeholders who need a clear, policy-oriented summary of CPT code 82013.